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Abstract
Objective—Delirium is a highly prevalent syndrome of acute brain dysfunction among critically 
ill patients that has been linked to multiple risk factors such as age, pre-existing cognitive 
impairment, and use of sedatives; but to date the relationship between race and delirium is unclear. 
We conducted this study to identify whether African-American race is a risk factor for developing 
ICU delirium.
Design—A prospective cohort study.
Setting—Medical and Surgical ICUs of a university affiliated, safety-net hospital in Indianapolis, 
Indiana.
Patients—2087 consecutive admissions with 1008 African-Americans admitted to the ICU 
services from May 2009 to August 2012.
Interventions—None
Measurements and Main Results—Incident delirium defined as first positive Confusion 
Assessment Method for the ICU (CAM-ICU) result after an initial negative CAM-ICU; and 
prevalent delirium defined as positive CAM-ICU on first CAM-ICU assessment. The overall 
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incident delirium rate in African-Americans was 8.7% compared to 10.4% in Caucasians (P: 0.26). 
The prevalent delirium rate was 14% in both African-Americans and Caucasians (P: 0.95). 
Significant age and race interactions were detected for incident delirium (P: 0.02), but not for 
prevalent delirium (P: 0.3). The hazard ratio for incident delirium for African-Americans in the 
18–49 years age group compared to Caucasians of similar age was 0.4 (0.1– 0.9). The hazard and 
odds ratios for incident and prevalent delirium in other groups were not different.
Conclusions—African-American race does not confer any additional risk for developing 
incident or prevalent delirium in the ICU. Instead younger African-Americans tend to have lower 
rates of incident delirium compared to similar age Caucasians.
Introduction
Delirium is a syndrome of acute brain dysfunction characterized by altered consciousness 
with a reduced ability to focus, sustain, or shift attention that develops quickly and fluctuates 
over the course of the day.[1] Delirium is highly prevalent in critically ill patients;[2–6] and 
is associated with greater lengths of intensive care unit (ICU) and hospital stay, mortality, 
and cost of care.[3–5] Multiple risk factors such as age, pre-existing cognitive impairment, 
and use of sedatives have been implicated in delirium development in the ICU,[7–10] but 
thus far any relationship between race and delirium has not been systematically evaluated.
Race, either as a biological construct or a social construct has shown to be a contributing 
factor to various chronic disease conditions such as inflammatory bowel disease,[11] 
congestive heart failure[12] and cognitive impairment.[13–15] Recently, racial differences 
have been elucidated in critical illness with African-Americans having a higher prevalence 
of sepsis compared to whites,[16] higher rates of cardiac arrest,[17, 18] noncardiogenic 
acute respiratory failure,[19] and venous thromboembolism.[20] Race not only affects 
disease prevalence but also clinical manifestations, severity, and mortality.[12–14, 21] 
Although access to care has been the presumed default factor responsible for such 
disparities, recent evidence has shown that the relationship between race and disease is 
complicated with race modifying the disease through multiple mechanisms including genetic 
susceptibility, presence of comorbid conditions, socioeconomic status, and access to care.
[12, 16, 22, 23] The attributable effect of race on chronic cognitive impairment has been 
mentioned in prior studies,[13, 14] but its contribution to acute brain dysfunction in the form 
of delirium in the ICU is unknown. We conducted a prospective, observational study with 
the objective to identify whether African-American race is independently associated with 
ICU delirium.
Materials and Methods
Indiana University Center for Aging Research (IU-CAR) is a research entity at Indiana 
University School of Medicine that has conducted multiple clinical studies on cognitive 
impairment over the last two decades.[24–28] A characteristic feature of all the studies is a 
significant representation of the African-American community with up to 50% of study 
subjects representing the minority race. In 2009, Indiana University Delirium working group 
consisting of IUCAR and the Pulmonary/ Critical Care division of Indiana University started 
a randomized, clinical trial known as the “Pharmacological Management of Delirium 
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(PMD)” study.[29] As part of the enrollment process for the trial, patients admitted to the 
ICUs are screened daily for delirium. The presence of a large screening cohort with a 
significant number of African-American participants in the PMD trial allowed us to examine 
the relationship between African American race and delirium. This study was approved by 
the Research Compliance Administration of Indiana University-Purdue University at 
Indianapolis.
Study Setting
Consecutive patients admitted to ICU services of Wishard Memorial Hospital (WMH), now 
known as Eskenazi Health from May 2009 to August 2012 were included in this 
observational study. WMH is a 457-bed; university-affiliated, safety-net public hospital 
staffed by Indiana University School of Medicine faculty and house-staff. It has an 8-bed 
surgical ICU (SICU), and a 14-bed medical/coronary ICU (MICU).
Inclusion and Exclusion Criteria
Inclusion criteria: 1) admitted to the WMH ICUs and 2) age ≥ 18 years. Exclusion criteria: 
1) not English speaking; 2) hearing impaired; 3) legally blind; 4) admitted with alcohol 
intoxication; 5) prisoners; 6) having an Axis 1 Psychiatric disorder; 7) persistently comatose 
as defined by Richmond Agitation Sedation Scale (RASS)[30] of −4 or −5 throughout the 
ICU stay; or 8) pregnant/nursing.
Screening and Outcome Measures
Richmond Agitation Sedation Scale (RASS)[30] and the Confusion Assessment Method for 
the ICU (CAM-ICU)[31] were used to assess patients’ sedation status and delirium 
respectively. Trained research assistants performed twice daily RASS and CAM-ICU 
assessments after patients’ ICU admission until the patients became delirious, died or were 
discharged from the ICU. A cut off of RASS ≥ −3 (i.e., any response to verbal stimulation) 
was used to identify CAM-ICU eligible patients. Patients were considered delirious if they 
had a positive CAM-ICU result, achieved by showing signs of acute change in mental status 
or fluctuating course, displaying features of inattention, and either disorganized thinking or 
altered level of consciousness.[31] Patients were deemed comatose if their RASS scores 
were −4 (responsive to physical but not to verbal stimulus) or −5 (unresponsive to verbal and 
physical stimulus).[30] Prevalent delirium was defined as a positive CAM-ICU result on the 
first delirium assessment during the ICU stay. Incident delirium was defined as first positive 
CAM-ICU assessment after an initial negative CAM-ICU. Delirium subtypes were classified 
based on the RASS assessment at the time of the first positive CAM-ICU screen. 
Hyperactive delirium was defined as a positive CAM-ICU plus a positive RASS (+1 to +4). 
Hypoactive delirium was defined as a positive CAM-ICU plus a neutral or negative RASS (0 
to −3).
Data collection—Local electronic medical records, the Regenstrief Medical Record 
System (RMRS),32 was used to determine patients’ age, gender, race, insurance status, 
smoking and alcohol use, length of hospital stay and mortality. Race was documented within 
RMRS as reported by the patient or caregiver. Chronic Comorbidities and admission 
diagnoses were collected by reviewing ICD-9 codes in the RMRS. Drug exposure was 
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assessed by active orders identified through the RMRS. Drugs with anticholinergic 
properties were classified using the Anticholinergic Cognitive Burden Scale.[32–34] 
Severity of illness was calculated through the Acute Physiology Score (APS) derived from 
the Acute Physiology and Chronic Health Evaluation (APACHE) III score.[35] Medicaid 
status and Wishard Advantage, a local health plan provided to patients without insurance 
were utilized as a socioeconomic adjustor variable.
Statistical Analysis
Variables are presented as mean and standard deviations for continuous variables and 
proportions for categorical variables. We used Chi-square tests to evaluate for differences in 
categorical variables and two sample t-tests for continuous variables across race for each of 
the outcomes. For continuous variables with skewed distributions such as length of stay and 
APS, we used the Wilcoxon-rank sum test in place of the two sample t-test. Logistic 
regression models were used to assess the relationship between race and prevalent delirium 
while adjusting for other demographic and socioeconomic factors, disease severity, and 
comorbidity. Cox proportional hazards regression was used to model the time to incident 
delirium. Time dependent variables were assessed differently for the two sets of models. For 
the prevalence analysis, medications and coma were only marked as yes if they occurred 
prior to the first CAM-ICU assessment. Ventilation status was marked as yes if patient was 
on mechanical ventilation prior to or during the CAM-ICU assessment. For the incidence 
analysis, medications and coma status was entered as time-dependent variables. Medications 
and coma would be counted as not present until after the day which they were prescribed or 
occurred. All data analyses were performed using SAS 9.3 software (SAS Institute, Cary, 
NC).
Results
Study Population
2087 consecutive admissions from the MICU and SICU were included in the study after 
application of the exclusion criteria from May 2009 to August 2012. The prevalent cohort 
included all 2087 patients with an initial CAM-ICU evaluation. Only those with an initial 
negative CAM-ICU result and one or more subsequent CAM-ICU evaluations (1569 
admissions) were included in the incident cohort. The mean age of patients in the incident 
cohort was 59.7 years with 48% African-Americans. The mean age of the study subjects in 
the prevalent cohort was 58.6 years with 48% African-Americans. 9794 RASS and CAM-
ICU screens were performed during this time-period. Table 1 describes the baseline 
characteristics of both the incident and prevalent cohorts as stratified by race. There were 
more trauma patients in the Caucasian group as compared to African-Americans. Higher 
number of opioids, benzodiazepines, and haloperidol drugs were ordered in the Caucasian 
group. Both groups had comparable severity of illness and similar rates of mechanical 
ventilation and dementia diagnoses. Depression diagnosis was higher among Caucasians.
Incidence and Prevalence of Delirium in African Americans compared to Caucasians
150 patients develop incident delirium with an overall incidence rate of 9.5% (150/1569), 
whereas 293 patients in the prevalent cohort developed delirium (prevalent rate: 14%; 
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293/2087). The incidence in African-Americans was 8.7% (66/759) versus 10.4% in 
Caucasians (84/810) (P=0.26). The prevalence was 14.1% (142/1008) in African-Americans 
versus14% (151/1079) among Caucasians (P=0.95). The results did not change after 
adjusting for coma and other variables from Table 1. The median time to develop incident 
delirium was 4 (IQR 1–8) days. In both cohorts, there were higher numbers of hypoactive 
delirium cases as compared to hyperactive ones. Table 2 shows the incidence and prevalence 
results along with length of hospital stay and in-hospital mortality.
As age has been associated with delirium, the cohorts were further divided into three groups 
based on age (18–49 years, 50–64 years, and ≥ 65 years). The incident delirium rate was 
5.3% in African-Americans compared to 13% in Caucasians in the 18–49 years age-group 
(P=0.01); 9.9% vs 8.7% in 50–64 years age-group (P=0.65), and 9.7% vs 10.7% in the ≥ 65 
years group (P=0.68). In the 18–49 years sub-group, delirium prevalence in African-
Americans versus Caucasians was 10.9% vs 11.6% (P=0.79); 50–64 years (14.6% vs 
16.3 %; P=0.49) and ≥ 65 years (16% vs 12.8%, P=0.21). Figure 1 shows the breakup 
stratified by race and age.
Multivariate Analysis
The hazards ratio (HR) for incident delirium for African-Americans compared to Caucasians 
among all ages was 1.1 (CI: 0.8–1.6), whereas the odds ratio (OR) for prevalent delirium for 
African-Americans compared to Caucasians was 1.2 (CI: 0.8–1.7). After adjusting for 
baseline variables, an interaction term between race and delirium was tested for both 
incident and prevalent cohorts and was found to be significant for incident cohort, (P=0.02), 
but not for prevalent cohort (P=0.30). Table 3 shows the HR and OR for delirium associated 
with model variables after including the interaction term. Severity of illness, dementia and 
sepsis diagnoses, and haloperidol orders were associated with higher odds for prevalent 
delirium. Opioid orders and trauma diagnosis were associated with higher odds for incident 
delirium. The HR for African-Americans in the 18–49 years age group compared to similar 
age Caucasians was 0.4 (CI: 0.1–0.9) for incident delirium. The HR/ORs for incident or 
prevalent delirium in the other groups were not significant (Table 4). The interaction stayed 
significant with similar HR even with medications excluded from the final model.
Discussion
ICU acquired delirium has been associated with multiple factors,[7–10, 36] but the 
relationship between race and development of delirium among critically ill adults has not 
been well defined. We sought to determine if African-American race is independently 
associated with ICU delirium compared to Caucasians. Our study findings do not indicate 
that African-American race is associated with a higher rate of delirium development in the 
ICU. On the contrary, incident delirium rates were found to be lower in younger African-
Americans in the 18–49 years group as compared to Caucasians of similar age. No such 
differences were observed in the other age groups (50–64 years; ≥ 65 years). Given our strict 
definition of incident delirium requiring a negative CAM-ICU depicting a clear “brain-
dysfunction free” period prior to a positive CAM-ICU, it seems that African-American race 
in younger patients may be a factor protecting this group from development of ICU 
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acquired/incident delirium. This finding though did not translate into the prevalent cohort for 
younger African-Americans. This raises the question of an age-dependent interaction of race 
with ICU acquired risk factors. The very nature of this interaction given our limited 
understanding of the biological and social effects of race on delirium and other disease 
processes is not yet clear.
African-Americans tend to be disproportionately affected by disease conditions necessitating 
admission to the ICU such as sepsis,[16] cardiac arrests,[18] and respiratory failure[19] 
compared to whites. This coupled with the findings that they have a higher prevalence of 
cognitive impairment in the form of vascular dementia,[37] it seems to reason that they may 
have a higher delirium burden. This was not shown by our results as mentioned above. It 
could be because of comparable severity of illness scores and similar rates of mechanical 
ventilation between African-Americans and Caucasians in our study cohort along with 
equivalent number of sepsis, respiratory failure, and dementia diagnoses. We adjusted for all 
other relevant clinical factors that could contribute to delirium along with socioeconomic 
indicators through insurance status.
Further exploration of the 18–49 years age-group showed differences in the clinical 
characteristics between African-Americans and Caucasians with Caucasians more likely to 
have depression and be smokers. Caucasians were also in receipt of a higher number of 
benzodiazepine and opioid orders compared to African-Americans but the difference was 
not statistically significant (data shown in supplemental content Table). The differential rates 
of incident delirium in 18–49 age group persisted even after adjusting for the above factors 
and by analyzing the results without medication orders. The reasons behind lower rates of 
incident delirium among African-Americans are unclear and will need further exploration in 
future studies. The clinical implications of higher delirium incidence among younger 
Caucasians include raising awareness among healthcare personnel with implementation of 
personalized risk models along with targeted interventions to decrease delirium burden. 
Based on the vascular risk factors among African-Americans,[18, 37, 38] we were expecting 
a higher delirium burden in the ≥ 65 years age-group, but that was not shown by our results.
Similar to other studies evaluating the subtypes of delirium,[39, 40] we found a considerably 
higher number of hypoactive as opposed to hyperactive delirious cases on our first positive 
CAM-ICU screen. The rates of hyperactive and hypoactive delirium did not differ between 
African-Americans and Caucasians in both incident and prevalent cohorts. In contrast to 
other studies demonstrating a higher mortality among African-Americans,[22, 38, 41, 42] 
our in-hospital mortality rates were similar among African-Americans and Caucasians. A 
possible explanation may have been a similar case mix along with ready access to similar 
health care services and delivery at our local county hospital with majority of patients 
belonging to the urban greater Indianapolis area.
Evaluating the impact of race on disease prevalence, presentation, and clinical outcomes is 
complicated. Race could be classified purely as a genetic factor modifying the disease but 
this is an oversimplification as the physiologic changes resulting from gene disorders could 
never completely explain the disease burden discrepancy that currently exists between 
African-Americans and Caucasians. A better depiction of race could be organized taking 
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into consideration the certain social factors including socioeconomic status, access to 
healthcare, and health habits. An omission of socioeconomic status and considering only the 
biologic race variable has the potential of introducing residual confounding with a bias 
assessment of association between race and particular disease of interest.[43] We tried to 
reduce residual confounding by adjusting for Indiana Medicaid and Wishard Advantage 
insurance status, an indigent care program unique to our hospital as a socioeconomic 
indicator in the final model.
Our study has several limitations. a) The study was conducted at a single site, a county 
hospital providing care to an urban, indigent population of Indianapolis metro area and 
hence applicability to other settings is limited. This on the other hand provides us with a 
large minority population allowing us to conduct our analysis with confidence to control for 
multiple variables. In addition, patients belong to a particular geographic area providing us 
with a homogenous group with similar access to health care. b) We did not have education or 
income status as proxy variables for socioeconomic status available for our patients. We 
instead utilized the insurance status as a socioeconomic indicator. Also the RASS and CAM-
ICU assessments are not shown to be influenced by education. c) We used drug orders to 
adjust for drug exposure rather than drug dispensing, which may not accurately represent 
exposure to known delirium risk factors; however, we do not expect differences in 
medication administration due to race.
Our study also has several strengths. a) We had a diverse patient population with almost half 
African-Americans and half females in both African-Americans and Caucasian cohorts. b) 
We included all the relevant variables associated with delirium in the final analysis. c) As the 
study was conducted at a safety net hospital, our population irrespective of race had similar 
socio-demographic and socioeconomic characteristics. d) Valid and reliable sedation 
(RASS) and delirium (CAM-ICU) screening tools were administered. Unlike prior work 
determining the influence of race on cognitive impairment,[15] our measure of delirium was 
captured by trained research staff and not dependent on clinical documentation. e) Both 
RASS and CAM-ICU assessments were performed twice daily.
Conclusions
African-American race was not a risk factor for developing incident or prevalent delirium in 
the ICU. In fact younger African-Americans tend to have lower rates of incident delirium 
compared to Caucasians of similar age. This finding needs further confirmation in other 
studies.
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Figure 1. 
Incident and prevalent delirium rates in African-Americans and Caucasians
*P=0.01
Numbers on top of bars represent the number of delirious patients
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Table 3
Hazards Ratios (HR) and Odds Ratios (OR) for delirium in association with model variables
Variables Incident Cohort#
HR (95% CI)
Prevalent Cohort#
OR (95% CI)
Female 1.1 (0.8–1.6) 1.0 (0.7–1.4)
Insurancea 0.7 (0.5–1.0) 1.0 (0.7–1.5)
APSb 1.0 (1.0–1.05) 1.0 (1.0–1.09)
Mechanical Ventilation 3.0 (1.7–5.4) 8.5 (5.0–14.3)
MICU* vs SICU# 0.9 (0.6–1.4) 0.6 (0.4–1.0)
Opioidc 2.2 (1.1–4.3) 1.5 (0.9–2.5)
Benzodiazepined 0.7 (0.4–3.3) 1.2 (0.7–2.0)
Anticholinergic 1.3 (0.7–2.1) 0.8 (0.4–1.7)
Haloperidol 1.1 (0.7–1.7) 2.7 (1.6–4.7)
Depression 0.8 (0.4–1.6) 1.4 (0.8–2.5)
Hypertension 0.8 (0.5–1.2) 0.9 (0.6–1.2)
Dementia 0.7 (0.4–1.1) 1.5 (1.0–2.2)
Sepsis 1.2 (0.8–1.7) 1.7 (1.1–2.4)
Acute Respiratory
Failure
0.9 (0.6–1.4) 1.3 (0.8–1.9)
Trauma 0.5 (0.3–0.9) 1.0 (0.5–2.0)
Smoking 0.9 (0.6–1.4) 1.0 (0.7–1.5)
Alcohol 1.4 (0.7–2.6) 0.6 (0.3–1.3)
% RASSe 0 scores 0.9 (0.97–0.99) 0.06 (0.03–0.12)
Comaf 1.2 (0.8–2.0) 1.3 (0.8–1.9)
*
MICU: Medical intensive care unit;
#SICU: Surgical intensive care unit;
a
Medicaid/Wishard advantage;
bAPS: Acute Physiology Score;
cOpioids includes morphine, fentanyl;
e
Benzodiazepines include lorazepam, midazolam;
e
RASS; Richmond Agitation Sedation Scale.
#
Race*Age interaction=0.02 for incident cohort; 0.30 for prevalent cohort
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Table 4
Multivariate analysis showing hazard (HR) and odds ratios (OR)* for delirium for African Americans 
compared to Caucasians
Age (years) Incident Cohort Prevalent Cohort
HR (95% CI) OR (95% CI)
18–49 0.4 (0.1 – 0.9) 1.1 (0.5 – 2.1)
50–64 1.7 (0.9 – 2.7) 1.0 (0.6 – 1.7)
≥ 65 1.3 (0.8 – 2.2) 1.3 (0.9 – 1.8)
*
Hazard and Odds Ratios, 95% confidence intervals, and p-values were calculated from the logistic regression model with the race by age 
interaction using appropriate contrasts
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